Kanwal Raghav Selected Research

Janus Kinase 1

1/2024

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kanwal Raghav Research Topics

Disease

22	Neoplasms (Cancer) 01/2024 - 05/2014
21	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2017
7	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2014
6	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2016
5	Adenocarcinoma 09/2023 - 01/2017
3	Cholangiocarcinoma 01/2024 - 10/2018
2	Residual Neoplasm 10/2022 - 12/2020
2	Mesothelioma 11/2021 - 01/2021
2	Thrombosis (Thrombus) 01/2021 - 06/2017
1	Triple Negative Breast Neoplasms 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Prostatic Neoplasms (Prostate Cancer) 01/2024
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2023
1	Appendiceal Neoplasms (Appendix Cancer) 02/2023
1	Microsatellite Instability 11/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Disease Progression 01/2021
1	Rectal Neoplasms (Rectal Cancer) 12/2020
1	End Stage Liver Disease 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Portal Hypertension 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Carcinogenesis 12/2017
1	Liver Diseases (Liver Disease) 10/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Neoplasms, Cystic, Mucinous, and Serous 01/2017
1	Brain Diseases (Brain Disorder) 05/2014
1	Ascites 05/2014

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 09/2023 - 08/2017
5	Immune Checkpoint InhibitorsIBA 11/2022 - 11/2020
3	Circulating Tumor DNAIBA 01/2023 - 01/2022
3	Bevacizumab (Avastin)FDA Link 11/2021 - 05/2017
2	Tumor Biomarkers (Tumor Markers)IBA 09/2023 - 01/2017
2	MucinsIBA 02/2023 - 01/2017
2	trastuzumab deruxtecanIBA 01/2023 - 01/2021
2	Cetuximab (Erbitux)FDA Link 01/2023 - 08/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2021
2	durvalumabIBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2017
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2019
2	human ERBB2 proteinIBA 11/2020 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 12/2019 - 01/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 05/2017
2	Cytidine Triphosphate (CTP)IBA 08/2015 - 05/2014
1	Phosphotransferases (Kinase)IBA 01/2024
1	Janus Kinase 1IBA 01/2024
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024
1	Hormones (Hormone)IBA 01/2024
1	trifluridine tipiracil drug combinationIBA 02/2023
1	regorafenibIBA 02/2023
1	zanidatamabIBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	Gemcitabine FDA Link 01/2022
1	trametinibIBA 01/2022
1	RamucirumabIBA 01/2022
1	atezolizumabIBA 11/2021
1	Protons (Proton)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	tremelimumabIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Topoisomerase I InhibitorsIBA 01/2021
1	Insulin-Like PeptidesIBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 12/2019
1	Pregnenolone Carbonitrile (PCN)IBA 01/2019
1	Angiopoietin-2IBA 12/2018
1	Angiopoietin-1IBA 12/2018
1	Panitumumab (Vectibix)FDA Link 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	taxaneIBA 01/2018
1	ProteomeIBA 12/2017
1	CollagenIBA 12/2017
1	PaxillinIBA 08/2017
1	src-Family KinasesIBA 08/2017
1	Dasatinib (BMS 354825)FDA Link 08/2017
1	Capecitabine (Xeloda)FDA Link 05/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Uridine Monophosphate (UMP)IBA 01/2017
1	Carcinoembryonic AntigenIBA 01/2017
1	AntigensIBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 05/2014
1	Insulin (Novolin)FDA Link 05/2014

Therapy/Procedure

21	Therapeutics 02/2023 - 05/2014
8	Drug Therapy (Chemotherapy) 02/2023 - 01/2017
4	Radiotherapy 12/2021 - 06/2017
3	Immunotherapy 02/2023 - 11/2020
2	Cytoreduction Surgical Procedures 02/2023 - 01/2017
2	Proton Therapy 01/2021 - 01/2019
1	Hyperthermic Intraperitoneal Chemotherapy 02/2023
1	Transplantation 01/2020